keiko ochiai ogawa
Hiroshima University Hospital, Hiroshima University
Hiroshima, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
Hiroshima University Hospital, Hiroshima University
Hiroshima, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
AstraZeneca (United States)
Wilmington, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Faculty of Pharmacy, University of Lisbon
Lisbon, Portugal
Review Editor
Pharmacology of Anti-Cancer Drugs
Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs
National University of Singapore
Singapore, Singapore
Review Editor
Pharmacology of Anti-Cancer Drugs
Cancer Institute Hospital of Japanese Foundation for Cancer Research
kyoto, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS)
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Chinese Academy of Sciences (CAS)
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Cancer Institute Hospital of Japanese Foundation for Cancer Research
kyoto, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
Italian Institute of Technology (IIT)
Genova, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
Wuhan, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Alagappa University
Karaikudi, India
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Nebraska Medical Center
Omaha, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
National Research Council (CNR)
Roma, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
Ghent University
Ghent, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs